THE TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME - ARE DANTROLENE AND BROMOCRIPTINE USEFUL ADJUNCTS TO SUPPORTIVE CARE

被引：84

作者：

ROSEBUSH, PI

STEWART, T

MAZUREK, MF

机构：

[1] HARVARD UNIV,BETH ISRAEL HOSP,DEPT PSYCHIAT,BOSTON,MA 02215

[2] MCMASTER UNIV,MED CTR,DEPT MED,DIV NEUROL,HAMILTON L8N 3Z5,ONTARIO,CANADA

[3] MCMASTER UNIV,MED CTR,DEPT BIOMED SCI,DIV NEUROL,HAMILTON L8N 3Z5,ONTARIO,CANADA

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1991年 / 159卷

关键词：

D O I：

10.1192/bjp.159.5.709

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

In a prospective study of 20 patients with NMS, those who received dantrolene (2 patients) or bromocriptine (2 patients) or both (4 patients) tended to have a more prolonged course of illness and a greater incidence of sequelae than those treated with supportive care alone. These results do not indicate a useful role for dantrolene or bromocriptine in the treatment of NMS.

引用

页码：709 / 712

页数：4